表紙:遺伝子検査の世界市場 (2021-2027年):市場予測 (検査区分・用途・地域別)・産業動向・地域的展望・成長の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
995120

遺伝子検査の世界市場 (2021-2027年):市場予測 (検査区分・用途・地域別)・産業動向・地域的展望・成長の潜在性・価格動向・市場シェア

Genetic Testing Market Size By Test Type, By Application, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
遺伝子検査の世界市場 (2021-2027年):市場予測 (検査区分・用途・地域別)・産業動向・地域的展望・成長の潜在性・価格動向・市場シェア
出版日: 2021年03月05日
発行: Global Market Insights Inc.
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子検査の市場は今後数年で大幅な成長を示すと予測されています。慢性疾患の罹患率の上昇、予測的な遺伝子検査利用の増加、遺伝性疾患、癌、心血管疾患などの分野での製品利用の増加などの要因が同市場の成長を推進しています。タイプ別では、予測的検査の部門が2020年に5%のシェアを占め、今後数年に渡って力強い成長を示すと予測されています。また、用途別では、 癌の部門が2020年に75億米ドル超の規模を示し、今後も堅調な成長を示す見通しです。

当レポートでは、世界の遺伝子検査の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、検査区分・用途・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 産業考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性
  • 規制シナリオ
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 市場分析・予測:検査区分別

  • 予測検査
  • キャリア検査
  • 出生前・新生児検査
  • 診断検査
  • 薬理ゲノミクス検査
  • 栄養ゲノム検査
  • その他

第5章 市場分析・予測:用途別

  • 遺伝病
  • 循環器疾患
  • その他

第6章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • 戦略ダッシュボード
  • 23andMe, Inc
  • Abbott Laboratories
  • Ambry Genetics (Konica Minolta)
  • BGI
  • Biocartis Group NV
  • Bio-Helix Co , Ltd
  • bioM?rieux SA
  • Blueprint Genetics
  • Cepheid (Danaher Corporation)
  • deCODE Genetics (Amgen)
  • Eurofins Scientific
  • Illumina, Inc.
  • Invitae Corporation
  • LabCorp (Laboratory Corporation of America Holdings)
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers AG
図表

Data Tables

  • TABLE 1 Genetic testing industry 360 degree synopsis, 2016 - 2027
  • TABLE 2 Genetic testing market size, 2016 - 2020 (USD Million)
  • TABLE 3 Genetic testing market size, 2021 - 2027 (USD Million)
  • TABLE 4 Genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 5 Genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 6 Genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 7 Genetic testing market size, by application, 2021 - 2027 (USD Million)
  • TABLE 8 Genetic testing market size, by region 2016 - 2020 (USD Million)
  • TABLE 9 Genetic testing market size, by region 2021 - 2027 (USD Million)
  • TABLE 10 Industry impact forces
  • TABLE 11 Predictive testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 12 Predictive testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 13 Carrier testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 14 Carrier testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 15 Prenatal and newborn testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 16 Prenatal and newborn testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 17 Diagnostic testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 18 Diagnostic testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 19 Pharmacogenomic testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 20 Pharmacogenomic testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 21 Nutrigenomic testing market size, by region, 2016 - 2020 (USD Million)
  • TABLE 22 Nutrigenomic testing market size, by region, 2021 - 2027 (USD Million)
  • TABLE 23 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 24 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 25 Cancer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 26 Cancer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 27 Genetic diseases market size, by region, 2016 - 2020 (USD Million)
  • TABLE 28 Genetic diseases market size, by region, 2021 - 2027 (USD Million)
  • TABLE 29 Cardiovascular disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 30 Cardiovascular disease market size, by region, 2021 - 2027 (USD Million)
  • TABLE 31 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 32 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 33 North America genetic testing market size, by country, 2016 - 2020 (USD Million)
  • TABLE 34 North America genetic testing market size, by country, 2021 - 2027 (USD Million)
  • TABLE 35 North America genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 36 North America genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 37 North America genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 38 North America genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 39 U.S. genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 40 U.S. genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 41 U.S. genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 42 U.S. genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 43 Canada genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 44 Canada genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 45 Canada genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 46 Canada genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 47 Europe genetic testing market size, by country, 2016 - 2020 (USD Million)
  • TABLE 48 Europe genetic testing market size, by country, 2021 - 2027 (USD Million)
  • TABLE 49 Europe genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 50 Europe genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 51 Europe genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 52 Europe genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 53 Germany genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 54 Germany genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 55 Germany genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 56 Germany genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 57 UK genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 58 UK genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 59 UK genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 60 UK genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 61 France genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 62 France genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 63 France genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 64 France genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 65 Spain genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 66 Spain genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 67 Spain genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 68 Spain genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 69 Italy genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 70 Italy genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 71 Italy genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 72 Italy genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 73 Russia genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 74 Russia genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 75 Russia genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 76 Russia genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 77 Asia Pacific genetic testing market size, by country, 2016 - 2020 (USD Million)
  • TABLE 78 Asia Pacific genetic testing market size, by country, 2021 - 2027 (USD Million)
  • TABLE 79 Asia Pacific genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 80 Asia Pacific genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 81 Asia Pacific genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 82 Asia Pacific genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 83 Japan genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 84 Japan genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 85 Japan genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 86 Japan genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 87 China genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 88 China genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 89 China genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 90 China genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 91 India genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 92 India genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 93 India genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 94 India genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 95 Australia genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 96 Australia genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 97 Australia genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 98 Australia genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 99 South Korea genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 100 South Korea genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 101 South Korea genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 102 South Korea genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 103 Latin America genetic testing market size, by country, 2016 - 2020 (USD Million)
  • TABLE 104 Latin America genetic testing market size, by country, 2021 - 2027 (USD Million)
  • TABLE 105 Latin America genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 106 Latin America genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 107 Latin America genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 108 Latin America genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 109 Brazil genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 110 Brazil genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 111 Brazil genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 112 Brazil genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 113 Argentina genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 114 Argentina genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 115 Argentina genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 116 Argentina genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 117 Mexico genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 118 Mexico genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 119 Mexico genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 120 Mexico genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 121 MEA genetic testing market size, by country, 2016 - 2020 (USD Million)
  • TABLE 122 MEA genetic testing market size, by country, 2021 - 2027 (USD Million)
  • TABLE 123 MEA genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 124 MEA genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 125 MEA genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 126 MEA genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 127 South Africa genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 128 South Africa genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 129 South Africa genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 130 South Africa genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 131 Saudi Arabia genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 132 Saudi Arabia genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 133 Saudi Arabia genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 134 Saudi Arabia genetic testing market size, by external fixators, 2021 - 2027 (USD Million)
  • TABLE 135 UAE genetic testing market size, by test type, 2016 - 2020 (USD Million)
  • TABLE 136 UAE genetic testing market size, by test type, 2021 - 2027 (USD Million)
  • TABLE 137 UAE genetic testing market size, by application, 2016 - 2020 (USD Million)
  • TABLE 138 UAE genetic testing market size, by external fixators, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Genetic testing market size, 2016 - 2027 (USD Million)
  • FIG. 3 Growth potential analysis, by test type
  • FIG. 4 Growth potential analysis, by application
  • FIG. 5 Porter's analysis
  • FIG. 6 Strategy dashboard, 2020
  • FIG. 7 PESTEL analysis
目次
Product Code: 2490

Title:
Genetic Testing Market Size By Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), By Application (Cancer, Genetic Disease, Cardiovascular Disease), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027.

The genetic testing market is projected to record momentous gains over the forthcoming timeframe due to rising incidences of chronic disorders, increasing use of predictive genetic testing, and growing product application in genetic diseases, cancer, and cardiovascular diseases among others. Genetic testing is referred as a type of medical test that identifies changes in genes, chromosomes, or proteins.

It is very useful in numerous areas of medicine and could change the medical care the individual or his/her family receives. For instance, genetic testing could provide a diagnosis for a genetic condition like Fragile X syndrome or information regarding risk of developing cancer. These tests are usually performed on sample of skin, hair, amniotic fluid, blood or any other tissue.

With respect to type, the market for genetic testing is classified into nutrigenomic testing, pharmacogenomic testing, diagnostic testing, prenatal and newborn testing, carrier testing, predictive testing, and others. Predictive testing accounted for an overall market share of 5% in 2020 and is estimated to follow a strong growth trend over the coming years. Predictive genetic testing searches for genetic mutations or changes, that are related to disease.

These types of tests are new and are expanding class of medical tests, usually different in fundamental ways from standard medical diagnostic tests. Predictive genetic tests are done way before the individual shows any specific signs of a disease. These types of tests are also useful to individuals who might have a family history of a treatable genetic disorder.

In terms of application, the overall genetic testing market is categorized into cardiovascular disease, genetic disease, cancer, and others. In 2020, cancer segment accounted for more than $7.5 billion market value and will show similar growth over the coming years. Genetic testing helps to estimate the chances of developing cancer throughout an individual's lifetime.

Panel genetic tests for instance can be grouped into genes that are all linked with the risk of developing certain types of cancer such as colon cancer or breast cancer. From a regional frame of reference, in 2020, Latin America genetic testing market held around 5.5% of the overall market share and is anticipated to see tremendous growth over the coming years.

The growth is majorly ascribed to the rising incidences of chronic disorders across several countries of Latin America. For instance, in Brazil, the chronic noncommunicable diseases constitute a major health issue in large magnitude, accounting for nearly 72% causes of death, with 16.3% deaths because of cancer.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definition
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Genetic testing industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Test type trends
    • 2.1.3 Application trends
    • 2.1.4 Regional trends

Chapter 3 Genetic Testing Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Physician adoption of genetic tests into clinical care
      • 3.3.1.2 Technological advancements and availability of new tests
      • 3.3.1.3 Growing application of genetic testing in oncology and genetic diseases in North America
      • 3.3.1.4 Consumer interest in personalized medicines in Europe
      • 3.3.1.5 Growing demand for direct-to-consumer genetic testing
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High costs of genetic testing
      • 3.3.2.2 Dearth of experienced professionals and advanced infrastructure in developing and underdeveloped economies
  • 3.4 Growth potential analysis
    • 3.4.1 By test type
    • 3.4.2 By application
  • 3.5 Regulatory scenario
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
  • 3.8 PESTEL analysis

Chapter 4 Genetic Testing Market, By Test Type

  • 4.1 Key segment trends
  • 4.2 Predictive testing
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Carrier testing
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Prenatal and new-born testing
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Diagnostic testing
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.6 Pharmacogenomic testing
    • 4.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.7 Nutrigenomic testing
    • 4.7.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.8 Others
    • 4.8.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Genetic Testing Market, By Application

  • 5.1 Key segment trends
  • 5.2 Cancer
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Genetic diseases
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Cardiovascular disease
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Genetic Testing Market, By Region

  • 6.1 Key segment trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.2.2 Market size, by test type, 2016 - 2027 (USD Million)
    • 6.2.3 Market size, by application, 2016 - 2027 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.2.4.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.2.5.2 Market size, by application, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.3.2 Market size, by test type, 2016 - 2027 (USD Million)
    • 6.3.3 Market size, by application, 2016 - 2027 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.3.4.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.3.5.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.3.6.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.3.7.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.3.8 Italy
      • 6.3.8.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.3.8.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.3.9 Russia
      • 6.3.9.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.3.9.2 Market size, by application, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.4.2 Market size, by test type, 2016 - 2027 (USD Million)
    • 6.4.3 Market size, by application, 2016 - 2027 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.4.4.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.4.5 China
      • 6.4.5.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.4.5.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.4.6.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.4.7.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.4.8 South Korea
      • 6.4.8.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.4.8.2 Market size, by application, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.5.2 Market size, by test type, 2016 - 2027 (USD Million)
    • 6.5.3 Market size, by application, 2016 - 2027 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.5.4.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.5.5 Argentina
      • 6.5.5.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.5.5.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.5.6 Mexico
      • 6.5.6.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.5.6.2 Market size, by application, 2016 - 2027 (USD Million)
  • 6.6 MEA
    • 6.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 6.6.2 Market size, by test type, 2016 - 2027 (USD Million)
    • 6.6.3 Market size, by application, 2016 - 2027 (USD Million)
    • 6.6.4 South Africa
      • 6.6.4.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.6.4.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.6.5.2 Market size, by application, 2016 - 2027 (USD Million)
    • 6.6.6 UAE
      • 6.6.6.1 Market size, by test type, 2016 - 2027 (USD Million)
      • 6.6.6.2 Market size, by application, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Strategy dashboard, 2020
  • 7.2 23andMe, Inc
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 Abbott Laboratories
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Ambry Genetics (Konica Minolta)
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 BGI
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Biocartis Group NV
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Bio-Helix Co , Ltd
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 bioMérieux SA
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 Blueprint Genetics
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Cepheid (Danaher Corporation)
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 deCODE Genetics (Amgen)
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 SWOT analysis
  • 7.12 Eurofins Scientific
    • 7.12.1 Business Overview
    • 7.12.2 Financial data
    • 7.12.3 Product Landscape
    • 7.12.4 SWOT analysis
  • 7.13 Illumina, Inc.
    • 7.13.1 Business overview
    • 7.13.2 Financial data
    • 7.13.3 Product landscape
    • 7.13.4 Strategic outlook
    • 7.13.5 SWOT analysis
  • 7.14 Invitae Corporation
    • 7.14.1 Business overview
    • 7.14.2 Financial data
    • 7.14.3 Product landscape
    • 7.14.4 Strategic outlook
    • 7.14.5 SWOT analysis
  • 7.15 LabCorp (Laboratory Corporation of America Holdings)
    • 7.15.1 Business overview
    • 7.15.2 Financial data
    • 7.15.3 Product landscape
    • 7.15.4 Strategic outlook
    • 7.15.5 SWOT analysis
  • 7.16 Luminex Corporation
    • 7.16.1 Business overview
    • 7.16.2 Financial data
    • 7.16.3 Product landscape
    • 7.16.4 Strategic outlook
    • 7.16.5 SWOT analysis
  • 7.17 Myriad Genetics, Inc.
    • 7.17.1 Business overview
    • 7.17.2 Financial data
    • 7.17.3 Product landscape
    • 7.17.4 Strategic outlook
    • 7.17.5 SWOT analysis
  • 7.18 Natera, Inc.
    • 7.18.1 Business overview
    • 7.18.2 Financial data
    • 7.18.3 Product landscape
    • 7.18.4 Strategic outlook
    • 7.18.5 SWOT analysis
  • 7.19 Qiagen
    • 7.19.1 Business overview
    • 7.19.2 Financial Data
    • 7.19.3 Product landscape
    • 7.19.4 Strategic outlook
    • 7.19.5 SWOT Analysis
  • 7.20 Quest Diagnostics
    • 7.20.1 Business overview
    • 7.20.2 Financial data
    • 7.20.3 Product landscape
    • 7.20.4 Strategic outlook
    • 7.20.5 SWOT analysis
  • 7.21 Roche Diagnostics
    • 7.21.1 Business overview
    • 7.21.2 Financial data
    • 7.21.3 Product landscape
    • 7.21.4 Strategic outlook
    • 7.21.5 SWOT analysis
  • 7.22 Siemens Healthineers AG
    • 7.22.1 Business overview
    • 7.22.2 Financial data
    • 7.22.3 Product landscape
    • 7.22.4 Strategic outlook
    • 7.22.5 SWOT analysis